Literature DB >> 8481842

Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells.

H Yamato1, R Okazaki, T Ishii, E Ogata, T Sato, M Kumegawa, K Akaogi, N Taniguchi, T Matsumoto.   

Abstract

Previous reports demonstrated that the administration of large doses of 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] to animals with normal vitamin D supply causes an increase in bone volume with reduced bone resorption and decreased osteoclast number. The present study was undertaken to clarify if 24R,25(OH)2D3 has any inhibitor effect on the formation and function of osteoclasts. The effect of 24R,25(OH)2D3 on the formation of osteoclastic cells was examined by measuring the number of tartrate-resistant acid phosphatase-positive multinucleated cells (MNCs) formed from hemopoietic progenitor cells obtained from spleens of 5-fluorouracil-treated mice. Treatment with 1,25(OH)2D3 or parathyroid hormone fragment 1-34 [PTH(1-34)] stimulated osteoclast-like MNC formation in a dose-dependent manner. Addition of 24R,25(OH)2D3 alone showed a weak stimulatory effect on MNC formation at 10(-6) M, which appeared to be due to its binding to 1,25(OH)2D3 receptors. In contrast, when 24R,25(OH)2D3 was added together with 1,25(OH)2D3 or PTH(1-34), it inhibited osteoclast-like MNC formation stimulated by these hormones. A significant inhibition of MNC formation was observed with 10(-7) M 24R,25(OH)2D3, and the stimulatory effect of 1,25(OH)2D3 or PTH(1-34) was almost completely eliminated with 10(-6) M 24R,25(OH)2D3. Neither 24S,25(OH)2D3 nor 25(OH)D3 exhibited a similar inhibitory effect. The effect of 24R,25(OH)2D3 on the resorptive function of osteoclasts was examined by measuring the formation of resorption pits by mouse bone cells on dentine slices. Treatment with 24R,25(OH)2D3 also inhibited the resorption pit formation stimulated by 1,25(OH)2D3 or PTH(1-34) with similar dose response.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481842     DOI: 10.1007/bf00298729

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  31 in total

1.  Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.

Authors:  H Yamato; T Matsumoto; S Fukumoto; K Ikeda; S Ishizuka; E Ogata
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

2.  Increased mechanical strength of the vitamin D-replete rat femur by the treatment with a large dose of 24R,25(OH)2D3.

Authors:  T Nakamura; T Kurokawa; H Orimo
Journal:  Bone       Date:  1989       Impact factor: 4.398

Review 3.  Biochemical properties of 1 alpha, 25-dihydroxyvitamin D receptors.

Authors:  W R Wecksler; A W Norman
Journal:  J Steroid Biochem       Date:  1980-08       Impact factor: 4.292

4.  24, 25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation.

Authors:  A Ornoy; D Goodwin; D Noff; S Edelstein
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

5.  Increased bone volume and reduced bone turnover in vitamin D-replete rabbits by the administration of 24R,25-dihydroxyvitamin D3.

Authors:  T Nakamura; K Suzuki; T Hirai; T Kurokawa; H Orimo
Journal:  Bone       Date:  1992       Impact factor: 4.398

6.  Regulation of bone turnover and prevention of bone atrophy in ovariectomized beagle dogs by the administration of 24R,25(OH)2D3.

Authors:  T Nakamura; Y Nagai; H Yamato; K Suzuki; H Orimo
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

7.  A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells.

Authors:  Y Takada; M Kusuda; K Hiura; T Sato; H Mochizuki; Y Nagao; M Tomura; M Yahiro; Y Hakeda; H Kawashima
Journal:  Bone Miner       Date:  1992-06

8.  Interaction between 24R,25-dihydroxycholecalciferol and 1,25-dihydroxycholecalciferol on 45Ca release from bone in vitro.

Authors:  A Mahgoub
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

9.  Effects and interactions of 24R,25(OH)2D3 and 1,25(OH)2D3 on bone.

Authors:  H H Malluche; H Henry; W Meyer-Sabellak; D Sherman; S G Massry; A W Norman
Journal:  Am J Physiol       Date:  1980-05

10.  Osteonal remodeling and mechanical properties of the femoral cortex in rabbits treated with 24R,25(OH)2D3.

Authors:  T Nakamura; T Hirai; K Suzuki; H Orimo
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

View more
  6 in total

1.  Cellular and molecular effects of thiazolidinediones on bone cells: a review.

Authors:  Guillaume Mabilleau; Daniel Chappard; Michel F Baslé
Journal:  Int J Biochem Mol Biol       Date:  2011-06-20

2.  Development of a new method for obtaining osteoclasts from endosteal surfaces.

Authors:  L G May; C V Gay
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-05       Impact factor: 2.416

3.  Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.

Authors:  G Jablonski; B M Mortensen; K H Klem; L Mosekilde; C C Danielsen; J O Gordeladze
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

4.  Calcium regulating activity of 26,27-dimethyl analog of 24R,25-dihydroxyvitamin D3.

Authors:  T Miyahara; M Harada; S Kondo; H Komiyama; S Matsuda; A Miyanishi; M Matsumoto; W Xue-Ya; Y Ikemoto; A Sugure
Journal:  Calcif Tissue Int       Date:  1994-09       Impact factor: 4.333

5.  Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium.

Authors:  S R Chalkley; J Richmond; D Barltrop
Journal:  Occup Environ Med       Date:  1998-07       Impact factor: 4.402

6.  Inhibition of development of N,N'-dimethylhydrazine-induced rat colonic aberrant crypt foci by pre, post and simultaneous treatments with 24R,25-dihydroxyvitamin D3.

Authors:  E I Salim; H Wanibuchi; T Taniyama; Y Yano; K Morimura; S Yamamoto; S Otani; Y Nishizawa; H Morii; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1997-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.